Search

Search Constraints

You searched for: Author/Creator Ravaud, A.

Search Results

1. 2630 Avelumab (MSB0010718C), an anti-PD-L1 antibody, in patients with locally advanced or metastatic urothelial carcinoma: A phase Ib trial. (September 2015)

2. 2859 A multicenter phase II of sunitinib in patients with locally advanced or metastatic differentiated, anaplastic or medullar thyroid carcinoma: Mature data of THYSU study. (September 2015)

3. 308 Phase I of axitinib and everolimus in metastatic solid tumors and extension to metastatic renal cell carcinoma (mrcc): Results of EVAX study. (September 2015)

4. 433 Decrease of pro-angiogenic monocytes predicts clinical response to anti-angiogenic treatment in patients with metastatic renal cell carcinoma (mRCC). (September 2015)

7. OP0088 Immune-related adverse events of cancer immunotherapy – when inflammatory side effects are associated with survival: a single-centre prospective cohort study. (12th June 2018)

8. SAT0540 ONE-YEAR OUTCOMES AFTER RHEUMATIC IMMUNE-RELATED ADVERSE EVENTS FROM CHECKPOINT INHIBITORS. (2nd June 2020)